IBSA USA
Nicole Fruia is a seasoned sales professional with extensive experience in the pharmaceutical and medical sales industries. Currently serving as a Sales Professional at IBSA USA since September 2023, Fruia previously excelled at Amarin Corporation for nearly a decade, achieving over 1400% growth of Vascepa in the Dallas/Fort Worth Metroplex. Previous roles include Specialty Sales Representative at ABBVIE/QUINTILES, where Fruia demonstrated high sales performance, and Sales Representative at Ameritox Labs, launching a new territory with a notable 207% growth. Fruia's earlier experience includes specialty sales at Endo Pharmaceuticals and medical supply sales at DeRoyal, alongside a strong educational background with a Bachelor of Science in Speech Communication from Stephen F. Austin State University.
This person is not in the org chart
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.